MANAGEMENT OF PLEXIFORM NEUROFIBROMA WITH INTERFERON ALPHA

Citak E. C., Oguz A., KARADENİZ C., OKUR A., Memis L., Boyunaga Ö. L.

PEDIATRIC HEMATOLOGY AND ONCOLOGY, cilt.25, sa.7, ss.673-678, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 7
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1080/08880010802315983
  • Dergi Adı: PEDIATRIC HEMATOLOGY AND ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.673-678
  • Anahtar Kelimeler: child, interferon alpha, neurofibromatosis type 1, plexiform neurofibroma, OPIOID RECEPTOR, PHASE-I, PIRFENIDONE, CHILDREN, ADULTS, TRIAL, NF1
  • Gazi Üniversitesi Adresli: Evet

Özet

Plexiform neurofibroma is a relatively common but potentially devastating manifestation of neurofibromatosis type 1 (NF 1). A substantial number of plexiform neurofibroma causes morbidity. Various treatment modalities are considered to decrease pain. In this paper a case with plexiform neurofibroma causing severe pain and in whom alpha-interferon was used is presented.